Filing Details
- Accession Number:
- 0001415889-24-028286
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-04 17:20:07
- Reporting Period:
- 2024-12-02
- Accepted Time:
- 2024-12-04 17:20:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1070081 | Ptc Therapeutics Inc. | PTCT | Pharmaceutical Preparations (2834) | 043416587 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1707685 | Marie Christine Utter | C/O Ptc Therapeutics, Inc. 500 Warren Corporate Center Drive Warren NJ 07059 | Svp, Chief Accounting Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-12-02 | 3,105 | $51.00 | 55,533 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-12-02 | 2,497 | $51.34 | 53,036 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-12-02 | 608 | $52.24 | 52,428 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-12-02 | 14,695 | $51.00 | 67,123 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-12-02 | 9,919 | $51.53 | 57,204 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-12-02 | 4,776 | $52.45 | 52,428 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-12-02 | 3,105 | $0.00 | 3,105 | $51.00 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-12-02 | 14,695 | $0.00 | 14,695 | $51.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 14,695 | 2025-01-02 | No | 4 | M | Direct | |
| 0 | 2025-01-02 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on August 27, 2024.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.15 to $52.06 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.16 to $52.41 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.15 to $52.11 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.15 to $52.88 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Currently exercisable.
Billionaire Hedge Funds
